Emcure Pharmaceuticals
add_icon

Emcure Pharmaceuticals

1,713.60
-37.90
(-2.16%)
Market Cap
32,488.06 Cr
PE Ratio
35.27
Volume
70,086.00
Day High - Low
1,752.70 - 1,705.20
52W High-Low
1,830.00 - 1,047.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
32,488.06 Cr
EPS
48.77
PE Ratio
35.27
PB Ratio
6.71
Book Value
261.09
EBITDA
1,833.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
15.24
Debt to Equity
0.45
Analyst Rating and Forecast
- By Refinitiv from6 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+83.33 %
+83.33 %
Hold
Hold+16.67 %
+16.67 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Emcure Pharmaceuticals announced its schedule for analyst and investor meetings starting May 26, 2026. The company will participate in conferences hosted by Ambit Capital and 360 ONE Capital.
neutral
NSE Sustainability Ratings & Analytics Limited assigned an ESG rating of 21 to Emcure Pharmaceuticals for FY 2024-25, disclosed under SEBI Regulation 30.
positive
Emcure Pharmaceuticals published audited FY26 results in Financial Express & Loksatta on May 06, 2026. FY26 consolidated EPS stood at ₹48.77; standalone PAT at ₹7,329.59 million.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,844.60
#1 4,42,581.33
41.43
#1 54,729.00
9.71
#1 10,980
16.07
54.75
6,887.00
1,82,828.21
73.47
9,712.00
18.67
2,191
-1.02
66.48
4,486.20
1,51,833.39
66.60
11,539.40
6.99
1,911
26.24
61.90
1,399.20
1,13,024.67
29.32
27,711.70
-2.46
3,783
-55.32
61.92
1,307.20
1,09,104.54
26.47
33,593.30
-0.44
3,998
-86.05
52.61
1,038.95
1,04,542.68
20.35
26,719.70
13.65
5,242
7.82
69.40
2,281.80
1,04,288.12
#1 19.51
27,487.50
19.98
5,345
#1 87.72
47.33
2,479.40
1,02,350.89
53.58
14,277.60
12.03
1,750
31.75
62.34
1,463.50
85,000.32
25.77
32,345.60
9.43
3,484
1.99
52.91
1,343.50
72,529.73
81.91
6,812.90
#1 21.03
884
21.18
77.10

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
15.49 %
Net Income Growth
26.44 %
Cash Flow Change
-22.38 %
ROE
-9.82 %
ROCE
-1.72 %
EBITDA Margin (Avg.)
2.79 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
1,571
1,664
1,697
1,783
1,839
2,038
1,967
2,121
2,104
2,273
2,365
2,484
Expenses
1,261
1,337
1,381
1,460
1,479
1,621
1,608
1,724
1,687
1,794
1,909
1,990
EBITDA
311
327
316
323
360
417
359
397
417
479
456
494
Operating Profit %
19 %
20 %
17 %
18 %
19 %
19 %
18 %
19 %
20 %
21 %
19 %
19 %
Depreciation
67
70
84
91
94
97
97
97
100
105
105
106
Interest
52
59
61
66
59
46
32
39
27
33
38
46
Profit Before Tax
191
198
171
167
207
273
230
261
291
341
314
341
Tax
50
52
51
46
55
72
74
63
76
90
82
97
Net Profit
141
146
120
121
153
202
156
197
215
251
231
244
EPS in ₹
7.21
7.70
6.27
6.36
7.95
10.23
8.12
9.97
10.92
12.85
12.16
12.84

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
5,247
5,644
6,004
6,807
6,064
6,673
7,806
8,233
Fixed Assets
2,049
2,247
2,382
2,188
2,044
2,147
3,125
3,197
Current Assets
2,335
2,453
2,703
3,718
3,424
3,836
4,260
4,556
Capital Work in Progress
531
581
485
302
320
411
159
177
Investments
0
0
0
0
25
25
318
95
Other Assets
2,667
2,817
3,137
4,318
3,674
4,089
4,204
4,763
Total Equity & Liabilities
5,247
5,644
6,004
6,807
6,064
6,673
7,806
8,233
Current Liabilities
2,336
2,543
2,920
3,408
2,965
3,019
3,211
2,668
Non Current Liabilities
1,157
1,201
1,100
1,031
985
1,004
1,474
923
Total Equity
1,755
1,900
1,984
2,368
2,114
2,650
3,122
4,642
Reserve & Surplus
1,520
1,654
1,731
2,092
1,807
2,320
2,771
4,257
Share Capital
181
181
181
181
181
181
181
190

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-700
32
259
42
134
219
-58
Investing Activities
-409
-168
-257
-575
-468
-715
-96
Operating Activities
444
500
704
768
747
1,097
852
Financing Activities
-735
-301
-189
-152
-145
-164
-814

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
78.08 %
78.08 %
77.94 %
77.92 %
77.91 %
77.88 %
77.87 %
77.87 %
FIIs
1.76 %
2.91 %
3.05 %
3.07 %
2.86 %
3.29 %
3.59 %
3.35 %
DIIs
3.34 %
3.96 %
3.87 %
3.44 %
2.84 %
4.37 %
6.10 %
6.10 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.73 %
5.00 %
5.14 %
5.51 %
5.95 %
6.24 %
6.46 %
6.46 %
Others
9.10 %
10.04 %
10.00 %
10.06 %
10.44 %
8.22 %
5.98 %
6.22 %
No of Share Holders
4,98,006
1,52,914
1,43,449
1,39,671
1,33,549
1,26,169
1,18,863
1,22,189

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.19 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 1,406.40 1,444.25
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 1,345.75 1,249.80
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2025 1,036.35 1,073.60
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,405.55 1,421.25
14 Aug 2025 DIVIDEND Dividend
₹ 3.00 /share
14 Aug 2025 1,073.60 1,453.80
28 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2025 1,408.15 1,468.60
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,318.00 1,426.60
04 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2026 1,557.90 1,505.75
05 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 May 2026 1,638.00 1,793.20

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - US FDA Inspection At Our Formulations Facility Located At Sanand Ahmedabad Gujarat India.7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 11, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG RatingMay 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2026
Corporate Action-Board approves DividendMay 05, 2026
Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2026May 05, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 05 2026May 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 28, 2026
Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2026Apr 28, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Appointment Of Independent DirectorApr 27, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 27, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 02, 2026
Announcement under Regulation 30 (LODR)-AcquisitionApr 01, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 24, 2026
Update On Re-Appointment Of Independent DirectorsMar 24, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 24, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 24, 2026
Clarification On Volume Movement LetterMar 10, 2026
Clarification sought from Emcure Pharmaceuticals LtdMar 10, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 09, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On March 09 2026.Mar 09, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 02, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Incident Of Fire At Our Manufacturing Plant Located At Hinjawadi Pune MaharashtraFeb 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2026
Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Feb 04, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 04, 2026
Appointment of Company Secretary and Compliance OfficerFeb 04, 2026
Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2025.Feb 04, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On February 04 2026.Feb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 22, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.14%
67
0.14%
0.14%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.10%
50
0.00%
0.03%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.29%
27
-0.03%
0.06%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.03%
4
0.00%
0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.10%
3
0.00%
0.02%
DSP Nifty 500 Index Fund Direct-Growth
0.03%
1
0.00%
0.01%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.29%
1
-0.03%
0.06%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Dividend Yield Fund Direct-Growth
0.29%
0
0.00%
-0.01%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
3.32%
0
0.00%
0.01%
Aditya Birla Sun Life Retirement Fund - The 30s Plan Direct-Growth
1.27%
0
0.00%
-0.10%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.32%
0
0.00%
-0.04%
Angel One Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Groww Multicap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Business Cycles Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Equity Savings Fund Direct-Growth
0.41%
0
0.00%
0.01%
Groww Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Bajaj Finserv Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
4.26%
0
0.00%
-0.09%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.41%
0
0.00%
-0.01%
Bandhan Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Multi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
61.40
ATR(14)
Less Volatile
62.45
STOCH(9,6)
Neutral
64.85
STOCH RSI(14)
Neutral
49.19
MACD(12,26)
Bullish
2.81
ADX(14)
Weak Trend
21.30
UO(9)
Bearish
57.50
ROC(12)
Uptrend And Accelerating
3.62
WillR(14)
Neutral
-38.75

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1981. It develops, manufactures, and globally markets pharmaceutical products across various therapeutic areas. The company operates 13 manufacturing facilities in India and has a presence in over 70 countries, with a strong focus on India, Europe, and Canada. Emcure specializes...more
Listing Date
10 Jul, 2024(1 Years, 44 days)
Chairperson NameBerjis M Desai